Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system

Thrombosis Research

Volumn 133, Issue 5, 2014, Pages 908-913

  Bizjak, Nina ^a   Bajd, Franci ^a   Vidmar, Jernej ^b   Blinc, Aleš ^c   Perme, Maja Pohar ^b   Marder, Victor J ^d   Novokhatny, Valery ^e   Serša, Igor ^a,f  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Grifols   (United States)

^f EN FIST CENTRE OF EXCELLENCE   (Slovenia)

Author keywords

Hemodynamics; Microscopy; Plasmin; Plasminogen activator; Thrombolytic therapy

Indexed keywords

FIBRINOLYTIC AGENT; PLASMIN; PLASMINOGEN; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOTTING; DRUG EFFECTS; FIBRINOLYSIS; HEMODYNAMICS; HUMAN; IN VITRO STUDY; METABOLISM;

BLOOD COAGULATION; FIBRINOLYSIN; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HEMODYNAMICS; HUMANS; IN VITRO TECHNIQUES; PLASMINOGEN; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84898819892     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.02.008     Document Type: Article

References (21)

1. V.J. Marder Historical perspective and future direction of thrombolysis research: the re-discovery of plasmin J Thromb Haemost 9 Suppl. 1 2011 364 373
2. V.J. Marder, A. Blinc, T. Gruber, G. Tratar, M. Sabovic, and S. Starkman et al. Comparison of plasmin with recombinant tissue-type plasminogen activator in lysis of cerebral thromboemboli retrieved from patients with acute ischemic stroke Stroke 42 2011 2222 2228
3. V.J. Marder, A.J. Comerota, R.D. Shlansky-Goldberg, J.P. Davis, C. Deng, and K. Hanna et al. Safety of catheter-delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion: phase I results J Thromb Haemost 10 2012 985 991
4. R.D. Shlansky-Goldberg, A.H. Matsumoto, G.A. Baumbach, J.B. Siegel, R.D. Raabe, and T.P. Murphy et al. A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion J Thromb Haemost 6 2008 944 950
5. D. Collen, and B. Wiman Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma Blood 53 1979 313 324
6. E.K. Kruithof Plasminogen activator inhibitors-a review Enzyme 40 1988 113 121
7. M. Margaglione, G. Cappucci, M. d'Addedda, D. Colaizzo, N. Giuliani, and G. Vecchione et al. PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants Arterioscler Thromb Vasc Biol 18 1998 562 567
8. V.J. Marder, K. Landskroner, V. Novokhatny, T.P. Zimmerman, M. Kong, and J.J. Kanouse et al. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit Thromb Haemost 86 2001 739 745
9. V.V. Novokhatny, G.J. Jesmok, K.A. Landskroner, V.J. Marder, and T.P. Zimmerman Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis? Trends Pharmacol Sci 25 2004 72 75
10. F. Bajd, J. Vidmar, A. Blinc, and I. Sersa Microscopic clot fragment evidence of biochemo-mechanical degradation effects in thrombolysis Thromb Res 126 2010 137 143
11. H.L. Morrison Catheter-directed thrombolysis for acute limb ischemia Semin Intervent Radiol 23 2006 258 269
12. R. Chang, C.C. Chen, A. Kam, E. Mao, T.H. Shawker, and M.K. Horne 3rd. Deep vein thrombosis of lower extremity: direct intraclot injection of alteplase once daily with systemic anticoagulation-results of pilot study Radiology 246 2008 619 629
13. A. Blinc, and C.W. Francis Transport processes in fibrinolysis and fibrinolytic therapy Thromb Haemost 76 1996 481 491
14. V.J. Marder, and V. Novokhatny Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential J Thromb Haemost 8 2010 433 444
15. M. Matveyev, and S.P. Domogatsky Penetration of macromolecules into contracted blood clot Biophys J 63 1992 862 863
16. I. Sersa, J. Vidmar, B. Grobelnik, U. Mikac, G. Tratar, and A. Blinc Modelling the effect of laminar axially directed blood flow on the dissolution of non-occlusive blood clots Phys Med Biol 52 2007 2969 2985
17. G. Tratar, A. Blinc, M. Strukelj, U. Mikac, and I. Sersa Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro Thromb Haemost 91 2004 487 496
18. W.E. Holmes, L. Nelles, H.R. Lijnen, and D. Collen Primary structure of human alpha 2-antiplasmin, a serine protease inhibitor (serpin) J Biol Chem 262 1987 1659 1664
19. G. Leipnitz, C. Miyashita, M. Heiden, G. von Blohn, M. Kohler, and E. Wenzel Reference values and variability of plasminogen in healthy blood donors and its relation to parameters of the fibrinolytic system Haemostasis 18 Suppl. 1 1988 61 68
20. D.V. Sakharov, and D.C. Rijken Superficial accumulation of plasminogen during plasma clot lysis Circulation 92 1995 1883 1890
21. M. Sabovic, H.R. Lijnen, D. Keber, and D. Collen Correlation between progressive adsorption of plasminogen to blood clots and their sensitivity to lysis Thromb Haemost 64 1990 450 454